Impact of direct-acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers.
Lam L, Fontaine H, Lapidus N, Dorival C, Bellet J, Larrey D, Nahon P, Diallo A, Cagnot C, Lusivika-Nzinga C, Téoulé F, Hejblum G, Bourlière M, Pol S, Carrat F; ANRS/AFEF Hepather study group.
Lam L, et al. Among authors: lapidus n.
Pharmacoepidemiol Drug Saf. 2023 Apr;32(4):486-495. doi: 10.1002/pds.5576. Epub 2022 Dec 5.
Pharmacoepidemiol Drug Saf. 2023.
PMID: 36444965